Thomas P Winkler, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 5530 Wisconsin Ave, Suite #1455, Chevy Chase, MD 20815 Phone: 301-656-8630 Fax: 301-656-8631 |
Dr. Jerold Joseph Principato, M.D. Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 5315 Kenwood Ave, S, Chevy Chase, MD 20815 Phone: 301-530-5565 Fax: 301-530-2483 |
Leslie Fan Hao, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 5530 Wisconsin Ave, Suite #1455, Chevy Chase, MD 20815 Phone: 301-656-8630 Fax: 301-656-8631 |
Dr. Alan David Kornblut, MD FACS Otolaryngology Medicare: May Accept Medicare Assignments Practice Location: 5530 Wisconsin Avenue, Suite 535, Chevy Chase, MD 20815 Phone: 301-657-8834 |
Jessica C Shen, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 5454 Wisconsin Ave, #1535, Chevy Chase, MD 20815 Phone: 301-652-8847 |
Ravinder Dahiya, MD Otolaryngology - Otolaryngology/Facial Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 2 Wisconsin Cir, Suite 220, Chevy Chase, MD 20815 Phone: 301-652-8882 |
Nora Malaisrie, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 5454 Wisconsin Ave, Suite 1535, Chevy Chase, MD 20815 Phone: 301-652-8847 |
News Archive
Also in the news, Bloomberg reports that some employers may change their minds about offering employees insurance when tax advantages go up next year.
The new research from the National Centre for Register-based Research at Aarhus BSS is the first of its kind to offer a comprehensive description of the risks of double diagnosis within the ten major groups of mental disorders - also called comorbidity.
Mayo Clinic's Individualizing Medicine Conference, scheduled for Oct. 1-3, will draw experts from around the world to discuss the use of genomics in patient care. Physicians and researchers in this rapidly growing field are building a new type of medicine based on the genomic and molecular interactions that make each patient unique.
Cempra Pharmaceuticals today announced poster presentations on its novel fluoroketolide antibiotic, solithromycin (CEM-101), and the Company's proprietary front-loading oral dosing regimen of sodium fusidate, TAKSTA (CEM-102) at the 48th Annual Meeting of the Infectious Diseases Society of America in Vancouver, British Columbia.
› Verified 5 days ago